[Ip-health] 24 May 2011 HAI Europe Press Release HAI Europe injects public health perspective into European Research and Innovation

Press HAI Europe Press at haieurope.org
Tue May 24 04:02:11 PDT 2011


HAI Europe injects public health perspective into European Research and
Innovation Framework

 

24 May 2011

 

Last Friday, 20 May 2011, Health Action International (HAI) Europe
submitted a response to the European Commission consultation on the
Common Strategic Framework (CSF) for Research and Innovation, providing
feedback and recommendations for health and biomedical research within
the next EU research framework. The Commission paper included important
references to the societal impact of research and innovation, which was
welcomed by HAI Europe. However, in many cases the paper fell short of
promoting the public interest in policy-making, and maintained a narrow
focus on innovation linked to commercial benefits. 

 

 As a patient and consumer organisation, HAI Europe's response sought to
inject a citizen-based perspective, in particular for the future of
European health and medical research. The response reviewed the
Commission's paper from a public health perspective, analysing the
conclusions based on how well they rise to the challenge of demographic
ageing, a period of severely constrained healthcare budgets, and the
sustainability of European healthcare systems. In this context, the
omission of health as a societal challenge was disappointing. 

 

 "In the EU, and around the world, we are seeing government price cuts
and a problem of access to innovative medicines, which is a reflection
of the flawed sustainability inherent in the current R&D model," says
HAI Europe Projects Officer, Terri Beswick. "The new research and
innovation framework marks an opportunity for EU leadership on
alternative models of medical research and innovation that promote
public health goals; where societal impact means healthy citizens, not
just healthy profits."

 

HAI Europe's response outlined two specific initiatives that should be
advanced in the next CSF: Equitable Licensing and Exploration of New
Models of Innovation (in particular, innovation inducement prizes).

 

'Public funds for public good' is the overarching principle behind
equitable licensing. Several equitable licensing provisions are directly
applicable to the EU research context and goals. In particular, award
criteria that ensure access to outputs and knowledge as a fair and
reasonable return for the investment of public funds collected from
European tax-payers.

 

The response also called for exploration of new models of innovation in
the next CSF, in the form of pilot programmes for inducement prizes, or
feasibility studies for alternative models. This is in line with the
EU's own commitments to explore R&D funding with incentives that
dissociate the cost of R&D from the price of products, thereby promoting
access and research collaboration that is currently thwarted by
increasing IP protectionism. 

 

HAI hopes that the results of the consultation, which are due to be
presented at an EU Commission event on 10 June 2011, take account of
public interest perspectives, and demonstrate a shift towards health and
medical research and innovation that seeks to bring about positive and
valuable health impacts to European societies.

 

***

The full consultation response is available at:
http://haieurope.org/wp-content/uploads/2011/05/20-May-2011-Consultation
-Response-DG-Research-Green-Paper.pdf

 

For more information please contact:

 

Terri Beswick: terri at haieurope.org or Sophie Bloemen:
sophie at haieurope.org

 

 

 

                        

 

***

 

 

 

 

 




More information about the Ip-health mailing list